Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
VAN BEEK JEROEN B
Chief Commercial Officer at Kalaris Therapeutics. Filing since 3 Aug 2020.
CIK 0001743662
Company
Date
Role
Action
Shares
Amount
Of holding
KLRS
Kalaris Therapeutics, Inc.
16 Nov 2022
Chief Commercial Officer
Sold, plan not stated
16,074
$120.53K
4.6%
KLRS
Kalaris Therapeutics, Inc.
11 Nov 2022
Chief Commercial Officer
Sold, plan not stated
36,592
$299.90K
9.5%
KLRS
Kalaris Therapeutics, Inc.
10 Nov 2022
Chief Commercial Officer
Sold, plan not stated
13,109
$104.90K
3.3%
KLRS
Kalaris Therapeutics, Inc.
8 Nov 2022
Chief Commercial Officer
Sold, plan not stated
299
$2.39K
0.1%
KLRS
Kalaris Therapeutics, Inc.
19 Oct 2022
Chief Commercial Officer
Sold, plan not stated
1,070
$10.02K
0.3%
KLRS
Kalaris Therapeutics, Inc.
2 Sep 2022
Chief Commercial Officer
Sold, plan not stated
493
$3.89K
0.1%
KLRS
Kalaris Therapeutics, Inc.
16 Aug 2022
Chief Commercial Officer
Sold, plan not stated
15,590
$129.47K
3.9%
KLRS
Kalaris Therapeutics, Inc.
20 Jul 2022
Chief Commercial Officer
Sold, plan not stated
1,058
$5.52K
0.3%
KLRS
Kalaris Therapeutics, Inc.
3 Jun 2022
Chief Commercial Officer
Sold, plan not stated
515
$1.87K
0.1%
KLRS
Kalaris Therapeutics, Inc.
17 May 2022
Chief Commercial Officer
Sold, plan not stated
15,262
$67.17K
3.8%
KLRS
Kalaris Therapeutics, Inc.
20 Apr 2022
Chief Commercial Officer
Sold, plan not stated
852
$5.70K
0.2%
KLRS
Kalaris Therapeutics, Inc.
2 Mar 2022
Chief Commercial Officer
Sold, plan not stated
516
$4.65K
0.1%
KLRS
Kalaris Therapeutics, Inc.
16 Feb 2022
Chief Commercial Officer
Sold, plan not stated
15,322
$127.53K
3.8%
KLRS
Kalaris Therapeutics, Inc.
20 Jan 2022
Chief Commercial Officer
Sold, plan not stated
4,656
$40.75K
1.2%
KLRS
Kalaris Therapeutics, Inc.
2 Dec 2021
Chief Commercial Officer
Sold, plan not stated
514
$8.77K
0.1%
KLRS
Kalaris Therapeutics, Inc.
16 Nov 2021
Chief Commercial Officer
Sold, plan not stated
15,203
$321.26K
3.6%
KLRS
Kalaris Therapeutics, Inc.
1 Oct 2021
Chief Commercial Officer
Sold, plan not stated
3,413
$85.57K
0.8%
KLRS
Kalaris Therapeutics, Inc.
30 Sep 2021
Chief Commercial Officer
Sold, plan not stated
12,171
$306.29K
2.8%
KLRS
Kalaris Therapeutics, Inc.
29 Sep 2021
Chief Commercial Officer
Sold, plan not stated
1,000
$25.04K
0.2%
KLRS
Kalaris Therapeutics, Inc.
17 Sep 2021
Chief Commercial Officer
Sold, plan not stated
5,916
$148.36K
1.3%
KLRS
Kalaris Therapeutics, Inc.
2 Sep 2021
Chief Commercial Officer
Sold, plan not stated
513
$10.19K
0.1%
KLRS
Kalaris Therapeutics, Inc.
17 Aug 2021
Chief Commercial Officer
Sold, plan not stated
15,205
$270.95K
3.3%
KLRS
Kalaris Therapeutics, Inc.
3 Jun 2021
Chief Commercial Officer
Sold, plan not stated
508
$11.62K
0.1%
KLRS
Kalaris Therapeutics, Inc.
18 May 2021
Chief Commercial Officer
Sold, plan not stated
15,201
$346.58K
3.2%
KLRS
Kalaris Therapeutics, Inc.
2 Mar 2021
Chief Commercial Officer
Sold, plan not stated
512
$19.42K
0.1%
KLRS
Kalaris Therapeutics, Inc.
1 Mar 2021
Chief Commercial Officer
Sold, plan not stated
5,932
$230.03K
1.2%
KLRS
Kalaris Therapeutics, Inc.
23 Feb 2021
Chief Commercial Officer
Sold, plan not stated
2,118
$83.78K
0.4%
KLRS
Kalaris Therapeutics, Inc.
22 Feb 2021
Chief Commercial Officer
Sold, plan not stated
2,800
$119.12K
0.6%
KLRS
Kalaris Therapeutics, Inc.
19 Feb 2021
Chief Commercial Officer
Sold, plan not stated
4,165
$173.72K
0.8%
KLRS
Kalaris Therapeutics, Inc.
18 Feb 2021
Chief Commercial Officer
Sold, plan not stated
2,085
$84.79K
0.4%
KLRS
Kalaris Therapeutics, Inc.
17 Feb 2021
Chief Commercial Officer
Sold, plan not stated
17,496
$695.36K
3.4%
KLRS
Kalaris Therapeutics, Inc.
16 Feb 2021
Chief Commercial Officer
Sold, plan not stated
3,100
$129.77K
0.6%
KLRS
Kalaris Therapeutics, Inc.
2 Feb 2021
Chief Commercial Officer
Sold, plan not stated
48,910
$2.01M
8.7%
KLRS
Kalaris Therapeutics, Inc.
3 Aug 2020
Chief Commercial Officer
Bought
3,000
$51.00K
0.6%
34 decisions on file.
